• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织蛋白酶D和E处理人恒定链的潜在位点。

Potential sites for processing of the human invariant chain by cathepsins D and E.

作者信息

Kageyama T, Yonezawa S, Ichinose M, Miki K, Moriyama A

机构信息

Department of Cellular and Molecular Biology, Kyoto University, Inuyama, Japan.

出版信息

Biochem Biophys Res Commun. 1996 Jun 25;223(3):549-53. doi: 10.1006/bbrc.1996.0932.

DOI:10.1006/bbrc.1996.0932
PMID:8687433
Abstract

Seven peptides of 15-30 amino acid residues were synthesized that covered almost the entire sequence of the lumenal domain of the human invariant chain (Ii), and their hydrolysis by cathepsins D and E was investigated. Two sites were identified that were very susceptible to such cleavage. One site, the Leu174-Phe175 bond, was cleaved by both cathepsins, and the other site, the Met99-Gln100 bond, was specifically cleaved by cathepsin E. These two sites could be the sites at which native Ii is cleaved by aspartic proteinases. The cleavage of the Met99-Gln100 bond by cathepsin E might be important in the inactivation of Ii and its functional derivatives.

摘要

合成了7种由15 - 30个氨基酸残基组成的肽段,这些肽段几乎覆盖了人恒定链(Ii)腔结构域的整个序列,并研究了组织蛋白酶D和E对它们的水解作用。确定了两个对这种切割非常敏感的位点。一个位点,Leu174 - Phe175键,可被两种组织蛋白酶切割,另一个位点,Met99 - Gln100键,可被组织蛋白酶E特异性切割。这两个位点可能是天然Ii被天冬氨酸蛋白酶切割的位点。组织蛋白酶E对Met99 - Gln100键的切割可能在Ii及其功能衍生物的失活中起重要作用。

相似文献

1
Potential sites for processing of the human invariant chain by cathepsins D and E.组织蛋白酶D和E处理人恒定链的潜在位点。
Biochem Biophys Res Commun. 1996 Jun 25;223(3):549-53. doi: 10.1006/bbrc.1996.0932.
2
Natural processing sites for human cathepsin E and cathepsin D in tetanus toxin: implications for T cell epitope generation.
J Immunol. 1997 Nov 15;159(10):4693-9.
3
Class II-associated invariant chain peptide-independent binding of invariant chain to class II MHC molecules.II类分子相关恒定链肽非依赖性恒定链与II类主要组织相容性复合体分子的结合
J Immunol. 1999 Feb 1;162(3):1502-9.
4
Specificity of human cathepsin S determined by processing of peptide substrates and MHC class II-associated invariant chain.通过肽底物加工和MHC II类相关恒定链确定人组织蛋白酶S的特异性
Biol Chem. 2006 Oct-Nov;387(10-11):1503-11. doi: 10.1515/BC.2006.188.
5
Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine cathepsins in antigen presentation.来自恒定链p41形式的抑制性片段可在抗原呈递过程中调节半胱氨酸组织蛋白酶的活性。
J Biol Chem. 2008 May 23;283(21):14453-60. doi: 10.1074/jbc.M801283200. Epub 2008 Mar 24.
6
Invariant chain can bind MHC class II at a site other than the peptide binding groove.恒定链可以在肽结合槽以外的位点与MHC II类分子结合。
J Immunol. 1998 Nov 1;161(9):4777-84.
7
A role for the transmembrane domain in the trimerization of the MHC class II-associated invariant chain.跨膜结构域在MHC II类相关恒定链三聚化中的作用。
J Immunol. 1999 Sep 1;163(5):2704-12.
8
Synthesis and NMR structure of p41icf, a potent inhibitor of human cathepsin L.
J Am Chem Soc. 2003 Feb 12;125(6):1508-17. doi: 10.1021/ja0207908.
9
Studies on activities of invariant chain peptides on releasing or exchanging of antigenic peptides at human leukocyte antigen-DR1.关于恒定链肽在人白细胞抗原-DR1上释放或交换抗原肽活性的研究。
Arzneimittelforschung. 1999 Sep;49(9):791-9.
10
Cutting edge: a single, essential hydrogen bond controls the stability of peptide-MHC class II complexes.前沿:单个关键氢键控制肽 - 主要组织相容性复合体II类复合物的稳定性。
J Immunol. 1999 Oct 1;163(7):3567-71.

引用本文的文献

1
Targeted delivery of antigen processing inhibitors to antigen presenting cells via mannose receptors.通过甘露糖受体将抗原加工抑制剂靶向递送至抗原呈递细胞。
ACS Chem Biol. 2010 May 21;5(5):461-476. doi: 10.1021/cb100008p.
2
CD4(+) T cells induced by a DNA vaccine: immunological consequences of epitope-specific lysosomal targeting.DNA疫苗诱导的CD4(+) T细胞:表位特异性溶酶体靶向的免疫后果
J Virol. 2001 Nov;75(21):10421-30. doi: 10.1128/JVI.75.21.10421-10430.2001.